We use cookies to improve our services and to provide you with tailored content for an improved experience. By clicking "Accept", you consent to cookies.
Introducing Sublingual Semaglutide Tablets! An INJECTION-FREE option for GLP-1 compounded preparations. Ask your pharmacist about sublingual semaglutide tablets today!
Compounders can help relieve drug shortages, says Revelation Pharma’s CEO, but they need help from the FDA. Shawn Hodges was interviewed for the latest edition of Pharmaceutical Executive for a piece called “Drug Shortages May Have a Compounding Solution” where he discussed how 503B pharmacies can fill the gaps caused by commercial pharma shortages and logistics issues.
“If you look at the problem in general, the shortages are being caused by manufacturing problems, supply chain issues, economic factors, and regulatory issues. There are opportunities in certain instances where compounding pharmacies can fill the void until the manufacturers are able to produce the products.”
Shawn is just one of the amazing team members at Revelation Pharma, which isn't surprising — Revelation is
On April 10, members of the Alliance for Pharmacy Compounding, California compounders, and other stakeholders gathered at the California state capitol in Sacramento to spend the day meeting with 21 different offices of the state legislature to address the challenges compounders are facing in the state. Also there was Revelation Pharma’s government affairs associate, Katie Johnston.
Towards the end of 2023, Peter Koshland, owner of Koshland Pharm in San Francisco, began organizing an advocacy initiative to address the growing concerns with the California Board of Pharmacy, hiring Cynthia Guerrero of advocacy consultant California Strategies to help guide the process.
Koshland brought together 25 people with the support of multiple companies and compounding pharmacies nationwide. On April 10, it split into three groups, each of which would meet with seven state
Florida Representative Shane Abbott paid a visit to Revelation Pharma family member Everwell Specialty Pharmacy in Pensacola, Fla., where he had a dynamic conversation on pharmacy compounding, regulatory reform, and the hurdles confronting patients and pharmacists alike. Notably, Representative Abbott stands out as one of only two pharmacists serving in the Florida legislature; he also owns a pharmacy on the Florida panhandle.
A staunch advocate for healthcare affordability and transparency, Representative Abbott shared invaluable insights on key legislative endeavors aimed at tackling pressing issues such as current USP standards, compounding for drug shortages, and pharmacy benefit manager (PBM)
Tampa, FL – Revelation Pharma, a national network of compounding pharmacies, specializing in personalized medicine and compounding services, announces the successful acquisition of Kentucky’s Prospect Pharmacy's Compounding Book of Business. This strategic move reinforces Revelation Pharma's commitment to expanding its reach and enhancing services in the compounding pharmacy division.
The acquisition includes the transfer of all compounding patients and providers previously served by Prospect Pharmacy to one of Revelation Pharma's trusted pharmacies, PenCol Specialty Pharmacy. This transition ensures continuity of care and uninterrupted access to high-quality compounded medications for all former Prospect Pharmacy customers
"We are thrilled to welcome former Prospect Pharmacy compounding patients and providers to the PenCol Specialty Pharmacy family," stated Shawn Hodges, CEO of Revelation Pharma. "Our continued goal is to provide exceptional
